AmerisourceBergen Corporation
AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home…
Medical - Distribution
US, Conshohocken [HQ]
FA
Fundamental Analysis · Most Recent Quarter
A dedicated fundamental analysis might help you to get a quick overview
of the
financial stability. It is important to understand the
FA Algorithm
and the criterias before valuing it as a top-tier resource.
Fundamentals
Valuation
| Metric | Q1 | Q2 | Δ in % | |
|---|---|---|---|---|
| EV/EBITDA | 6.08 | 44.93 | 42.36 | |
| Graham Fair Price | -2.64 | 17.09 | 17.56 | |
| PEG | 305.24 | -0.96 | 0.24 | |
| Price/Book | -13.71 | 39.49 | 45.77 | |
| Price/Cash Flow | -4.99 | -48.89 | 51.45 | |
| Prices/Earnings | 66.01 | 28.79 | 17.34 | |
| Price/Sales | 22.65 | 0.71 | 0.58 | |
| Price/FCF | -4.99 | -48.89 | 51.45 | |
| Naive Interpretation | member | |||
01 - Valuation ·
Weak
Fundamentals
Profitability
| Metric | Q1 | Q2 | Δ in % | |
|---|---|---|---|---|
| Gross Profit Margin | 11.33 | 0.03 | 0.03 | |
| Operating Margin | 23.36 | 0.01 | 0.01 | |
| ROA | -29.15 | < 0.005 | < 0.005 | |
| ROE | 0.66 | 0.34 | -48.02 | |
| ROIC | 0.10 | 0.12 | 20.24 | |
| Naive Interpretation | member | |||
02 - Profitability ·
Not Interpreted
Fundamentals
Financial Growth
| Metric | Q1 | Q2 | Δ in % | |
|---|---|---|---|---|
| Debt QOQ | 0.10 | < 0.005 | 5299.53 | |
| Dividends QOQ | 0.08 | 0.02 | -80.56 | |
| EBIT QOQ | 0.58 | 0.17 | -70.77 | |
| EPS QOQ | 0.73 | -0.30 | -59.03 | |
| FCF QOQ | -0.51 | -2.22 | -336.67 | |
| Revenue QOQ | 0.05 | -0.05 | 9.94 | |
| Naive Interpretation | member | |||
03 - Financial Growth ·
Weak
Fundamentals
Leverage & Liquidity
| Metric | Q1 | Q2 | Δ in % | |
|---|---|---|---|---|
| Assets Turnover | n.A. | n.A. | n.A. | |
| Days Inventory Outstanding (DIO) | 23.95 | 25.61 | 6.97 | |
| Days Sales Outstanding (DSO) | 26.90 | 29.79 | 10.72 | |
| Inventory Turnover | 3.76 | 3.51 | -6.51 | |
| Debt/Capitalization | 0.84 | 0.81 | -3.48 | |
| Quick Ratio | 0.48 | 0.50 | 2.62 | |
| Naive Interpretation | member | |||
04 - Leverage & Liquidity ·
Weak
Fundamentals
Per Share Metrics
| Metric | Q1 | Q2 | Δ in % | |
|---|---|---|---|---|
| Book Value | 4.56 | 6.15 | 35.04 | |
| Cash | 14.85 | 10.38 | -30.16 | |
| Capex | -0.37 | -0.57 | -52.44 | |
| Free Cash Flow | 4.05 | -4.97 | 22.64 | |
| Revenue | 361.12 | 343.09 | -4.99 | |
| Naive Interpretation | member | |||
05 - Per Share Metrics ·
Weak
Fundamentals
Financial Health
06 - Financial Health ·
Bad